Pustular psoriasis flare‐up in a patient with COVID‐19

The various cutaneous manifestations have lately appeared in the setting of COVID‐19. Psoriasis flare‐ups have been reported during a COVID‐19 infection.

[1]  A. Babazadeh,et al.  Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge , 2021, Journal of medical virology.

[2]  A. Babazadeh,et al.  Neurological manifestations in COVID-19: an overview , 2021 .

[3]  S. Seneviratne,et al.  Gastrointestinal manifestations in COVID-19 , 2021, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[4]  K. Skorecki,et al.  Renal Manifestations of Covid-19: Physiology and Pathophysiology , 2021, Journal of clinical medicine.

[5]  G. Gürel,et al.  Exacerbation of psoriasis following hydroxychloroquine in a patient with suspected COVID‐19 , 2021, Dermatologic therapy.

[6]  I. Jaiyesimi,et al.  Hematologic disorders associated with COVID-19: a review , 2021, Annals of Hematology.

[7]  A. Babazadeh,et al.  A review of cardiac involvement in COVID-19 infection , 2020 .

[8]  W. Pichler,et al.  Drug-related relapses in drug reaction with eosinophilia and systemic symptoms (DRESS) , 2020, Clinical and Translational Allergy.

[9]  Tewodros Shibabaw.  Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy , 2020, Journal of inflammation research.

[10]  J. Achkar,et al.  Gastrointestinal manifestations of COVID-19. , 2020, Cleveland Clinic journal of medicine.

[11]  Ömer Kutlu,et al.  Psoriasis and COVID‐19: A narrative review with treatment considerations , 2020, Dermatologic therapy.

[12]  A. Khachemoune,et al.  The effect of the “stay‐at‐home” policy on requests for dermatology outpatient clinic visits after the COVID‐19 outbreak , 2020, Dermatologic therapy.

[13]  A. Karadağ,et al.  Cutaneous signs in COVID‐19 patients: A review , 2020, Dermatologic therapy.

[14]  Ömer Kutlu,et al.  Dermatological diseases presented before COVID‐19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID‐19? , 2020, Dermatologic therapy.

[15]  L. Rudnicka,et al.  Cyclosporine therapy during the COVID-19 pandemic , 2020, Journal of the American Academy of Dermatology.

[16]  M. Tabary,et al.  A challenging case of psoriasis flare-up after COVID-19 infection , 2020, The Journal of dermatological treatment.

[17]  Z. Akbari,et al.  Hydroxychloroquine-induced Stevens–Johnson syndrome in COVID-19: a rare case report , 2020, Oxford medical case reports.

[18]  T. Lotti,et al.  Cutaneous sıde‐effects of the potential COVID‐19 drugs , 2020, Dermatologic therapy.

[19]  Q. Ye,et al.  The pathogenesis and treatment of the `Cytokine Storm' in COVID-19 , 2020, Journal of Infection.

[20]  Ömer Kutlu,et al.  A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID‐19: Will cases of psoriasis increase after COVID‐19 pandemic? , 2020, Dermatologic therapy.

[21]  M. Lebwohl,et al.  An update on generalized pustular psoriasis , 2019, Expert review of clinical immunology.

[22]  A. Navarini,et al.  Generalized pustular psoriasis – a model disease for specific targeted immunotherapy, systematic review , 2018, Experimental dermatology.

[23]  Drew H Barnes,et al.  Cytokines in psoriasis. , 2015, Cytokine.

[24]  N. Arslan,et al.  Levetiracetam induced psoriasiform drug eruption: a rare case report , 2015, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[25]  T. S. Sathyanarayana Rao,et al.  Psychosomatic paradigms in psoriasis: Psoriasis, stress and mental health , 2013, Indian journal of psychiatry.

[26]  E. Cowen,et al.  Autoinflammatory pustular neutrophilic diseases. , 2013, Dermatologic clinics.

[27]  G. Hughes,et al.  Increased cutaneous reactions to hydroxychloroquine (Plaquenil) possibly associated with formulation change: comment on the letter by Alarcón. , 2002, Arthritis and rheumatism.

[28]  G. Lomholt.  FOR PSORIASIS — , 1965, Maanedsskrift for praktisk laegegerning og social Medicin.